Faeth Therapeutics, Inc.
FTH- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001829802
In the last 90 days, Faeth Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 45 institutions reported holding it in 13F filings for Q2 2026, worth $333.8M in total; no superinvestor holds it.
13F holders, Q3 2021
Institutional positions in Faeth Therapeutics, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 42
- +8 vs. Q2 2021
- Shares held
- 3.53M
- +1.21M (+51.9%) vs. Q2 2021
- Total value
- $37.1M
- +$14.4M (+63.6%) vs. Q2 2021
- New holders
- 14
- 16 more added
- Sold out
- 6
- 9 more reduced
Compare with Q2 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting FTH on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 45 | $333.8M |
| Q1 2026 | 30 | $68.0M |
| Q4 2025 | 10 | $514.8K |
| Q3 2025 | 9 | $466.2K |
| Q2 2025 | 10 | $600.0K |
| Q1 2025 | 20 | $760.2K |
| Q4 2024 | 24 | $1.16M |
| Q3 2024 | 19 | $1.32M |
| Q2 2024 | 24 | $1.31M |
| Q1 2024 | 25 | $2.43M |
| Q4 2023 | 24 | $2.05M |
| Q3 2023 | 23 | $2.38M |
| Q2 2023 | 26 | $3.58M |
| Q1 2023 | 27 | $4.71M |
| Q4 2022 | 28 | $3.93M |
| Q3 2022 | 31 | $4.47M |
| Q2 2022 | 40 | $7.06M |
| Q1 2022 | 43 | $8.21M |
| Q4 2021 | 38 | $19.7M |
| Q3 2021 | 42 | $37.1M |
| Q2 2021 | 34 | $22.7M |
| Q1 2021 | 40 | $45.8M |
Institutions, Q3 2021
Shares, value and share of portfolio for each institution holding Faeth Therapeutics, Inc.; share changes are against Q2 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Lindbrook Capital, LLC | 27 | $0 | 0.00% | +27 | New |
| Wells Fargo & Company | 61 | $1.00K | 0.00% | −11,020−99.4% | Reduced |
| US Bancorp | 91 | $1.00K | 0.00% | +91 | New |
| Signaturefd, LLC | 142 | $1.00K | 0.00% | +142 | New |
| Parallel Advisors, LLC | 54 | $1.00K | 0.00% | +54 | New |
| Banque Cantonale Vaudoise | 300 | $3.00K | 0.00% | 00.0% | Unchanged |
| Investment Research & Advisory Group, Inc. | 1,400 | $5.00K | 0.00% | +1,400 | New |
| Tower Research Capital LLC (TRC) | 775 | $8.00K | 0.00% | −635−45.0% | Reduced |
| UBS Group AG | 1,009 | $11.0K | 0.00% | +315+45.4% | Added |
| Ameritas Investment Partners, Inc. | 1,602 | $17.0K | 0.00% | +982+158.4% | Added |
| Legal & General Group Plc | 1,674 | $18.0K | 0.00% | +1,081+182.3% | Added |
| Royal Bank of Canada | 2,411 | $25.0K | 0.00% | +1,732+255.1% | Added |
| Citigroup Inc | 2,409 | $25.0K | 0.00% | +2,047+565.5% | Added |
| Morgan Stanley | 3,315 | $35.0K | 0.00% | −104,411−96.9% | Reduced |
| New York State Common Retirement Fund | 5,413 | $57.0K | 0.00% | +17+0.3% | Added |
| Bank of America Corp | 8,514 | $90.0K | 0.00% | −3,161−27.1% | Reduced |
| Jane Street Group, LLC | 10,773 | $113.0K | 0.00% | +10,773 | New |
| California State Teachers Retirement System | 11,291 | $119.0K | 0.00% | +762+7.2% | Added |
| American International Group, Inc. | 11,437 | $120.0K | 0.00% | +7,171+168.1% | Added |
| Deutsche Bank AG | 12,021 | $126.0K | 0.00% | +7,368+158.3% | Added |
| SG Americas Securities, LLC | 12,614 | $133.0K | 0.00% | +12,614 | New |
| Manufacturers Life Insurance Company, The | 13,478 | $142.0K | 0.00% | +13,478 | New |
| BFT Financial Group, LLC | 14,845 | $156.0K | 0.03% | +14,845 | New |
| Rhumbline Advisers | 16,579 | $174.0K | 0.00% | +16,579 | New |
| Pura Vida Investments, LLC | 22,603 | $238.0K | 0.02% | 00.0% | Unchanged |
| Mission Creek Capital Partners, Inc. | 32,784 | $345.0K | 0.06% | +32,784 | New |
| Tao Capital Management LP | 32,784 | $345.0K | 0.09% | +32,784 | New |
| Alps Advisors Inc | 37,484 | $394.0K | 0.00% | −2,802−7.0% | Reduced |
| Charles Schwab Investment Management Inc | 46,579 | $491.0K | 0.00% | −8,386−15.3% | Reduced |
| Bank of New York Mellon Corp | 47,066 | $495.0K | 0.00% | +28,635+155.4% | Added |
| Moore Capital Management, LP | 49,341 | $519.0K | 0.01% | −78,159−61.3% | Reduced |
| Nuveen Asset Management, LLC | 56,349 | $548.0K | 0.00% | +43,813+349.5% | Added |
| Truist Financial Corp | 70,374 | $740.0K | 0.00% | +70,374 | New |
| Duquesne Family Office LLCSuperinvestorDuquesne Family Office | 100,000 | $1.05M | 0.03% | 00.0% | Unchanged |
| Citadel Advisors LLC | 123,258 | $1.30M | 0.00% | −160,409−56.5% | Reduced |
| Northern Trust Corp | 160,758 | $1.69M | 0.00% | +85,747+114.3% | Added |
| State Street Corp | 168,031 | $1.77M | 0.00% | +68,031+68.0% | Added |
| JPMorgan Chase & Co | 169,340 | $1.78M | 0.00% | −9,738−5.4% | Reduced |
| Millennium Management LLC | 258,659 | $2.72M | 0.00% | +258,659 | New |
| Geode Capital Management, LLC | 273,978 | $2.88M | 0.00% | +132,169+93.2% | Added |
| Vanguard Group Inc | 746,759 | $7.86M | 0.00% | +359,006+92.6% | Added |
| BlackRock Inc. | 1,000,322 | $10.5M | 0.00% | +636,856+175.2% | Added |
| Formula Growth Ltd | 0 | $0 | 0.00% | −100,000−100.0% | Sold out |
| Zimmer Partners, LP | 0 | $0 | 0.00% | −46,000−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Tudor Investment Corp Et Al | 0 | $0 | 0.00% | −28,111−100.0% | Sold out |
| Two Sigma Advisers, LP | 0 | $0 | 0.00% | −23,200−100.0% | Sold out |
| Two Sigma Investments, LP | 0 | $0 | 0.00% | −18,551−100.0% | Sold out |